Completed PHASE4 INTERVENTIONAL NCT00162344

A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.

AceP-D: Non-invasive Assessment of Atypical Chest Pain in Patients With Diabetes

Sponsor: Lantheus Medical Imaging

Conditions Diabetes

Interventions Technetium Tc99m Sestamibi

Updated 6 times since 2017 Last updated: Apr 14, 2011 Started: Dec 31, 2003 Primary completion: Dec 31, 2005 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00162344, this PHASE4 trial focuses on Diabetes and remains completed. Sponsored by Lantheus Medical Imaging, it has been updated 6 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Dec 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lantheus Medical Imaging

Data source: Lantheus Medical Imaging

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States , Chicago, United States , Columbus, United States , Detroit, United States , Houston, United States , Indianapolis, United States , Minneapolis, United States , Mission Viejo, United States , Montreal, Canada , Rancho Santa Fe, United States and 2 more locations